Article Text
Featured correspondence
The authors’ reply:
Statistics from Altmetric.com
We thank Dr Szymañski for his critical review1 of our paper on the therapeutic options for patients with a systemic right ventricle.2 We agree with the author that studies on the effect of angiotensin converting enzyme (ACE) inhibitors, and angiotensin II receptor (AT-II) antagonists are hampered by the heterogeneity of the patient population, and that strict definition of the study population is of …
Footnotes
Provenance and peer review Not commissioned; not externally peer reviewed.